Fatty acid oxidation inhibition with PPARα activation (FOXIB/PPARα) for normalizing gene expression in heart failure?

Cardiovascular Research

Volumn 66, Issue 3, 2005, Pages 423-426

  Rupp, Heinz ^a,b   Rupp, Thomas P ^a   Maisch, Bernhard ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Molecular Cardiology Laboratory   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ETOMOXIR; OXFENICINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

DISEASE COURSE; DRUG ACTIVITY; EDITORIAL; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; GENE EXPRESSION; GLUCOSE UTILIZATION; HEART DILATATION; HEART FAILURE; LIPID STORAGE; NONHUMAN; PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL;

ANIMALS; CARNITINE O-PALMITOYLTRANSFERASE; CLINICAL TRIALS; ENZYME INHIBITORS; EPOXY COMPOUNDS; FATTY ACIDS; GENE EXPRESSION REGULATION; GLYCINE; HEART FAILURE, CONGESTIVE; HUMANS; HYPOGLYCEMIC AGENTS; OXIDATION-REDUCTION; PPAR ALPHA;

EID: 19444364923     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2005.03.023     Document Type: Editorial

References (16)

1. L.W. Stanton, L.J. Garrard, D. Damm, B.L. Garrick, A. Lam, and A.M. Kapoun Altered patterns of gene expression in response to myocardial infarction Circ Res 86 2000 939 945
2. 2+ exchange in heart failure Cardiovasc Res 57 2003 921 933
3. F. del Monte, R. Dalal, A. Tabchy, J. Couget, K.D. Bloch, and R. Peterson Transcriptional changes following restoration of SERCA2a levels in failing rat hearts FASEB J 18 2004 1474 1476
4. M.N. Sack, T.A. Rader, S. Park, J. Bastin, S.A. McCune, and D.P. Kelly Fatty acid oxidation enzyme gene expression is downregulated in the failing heart Circulation 94 1996 2837 2842
5. M. van Bilsen, P.J. Smeets, A.J. Gilde, and G.J. van der Vusse Metabolic remodelling of the failing heart: the cardiac burn-out syndrome? Cardiovasc Res 61 2004 218 226
6. P.M. Barger, J.M. Brandt, T.C. Leone, C.J. Weinheimer, and D.P. Kelly Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth J Clin Invest 105 2000 1723 1730
7. V. Lionetti, A. Linke, M.P. Chandler, M.E. Young, M.S. Penn, and S. Gupte Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure Cardiovasc Res 66 2005 454 461
8. M. Turcani, and H. Rupp Modification of left ventricular hypertrophy by chronic etomoxir treatment Br J Pharmacol 126 1999 501 507
9. M.E. Young, F.A. Laws, G.W. Goodwin, and H. Taegtmeyer Reactivation of peroxisome proliferator-activated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart J Biol Chem 276 2001 44390 44395
10. H. Rupp, W. Schulze, and R. Vetter Dietary medium-chain triglycerides can prevent changes in myosin and SR due to CPT-1 inhibition by etomoxir Am J Physiol 269 1995 R630 R640
11. A. Zarain-Herzberg, and H. Rupp Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target Expert Opin Investig Drugs 11 2002 345 356
12. H. Rupp, and R. Vetter Sarcoplasmic reticulum function and carnitine palmitoyltransferase-1 inhibition during progression of heart failure Br J Pharmacol 131 2000 1748 1756
13. S. Schmidt-Schweda, and C. Holubarsch First clinical trial with etomoxir in patients with chronic congestive heart failure Clin Sci (Colch) 99 2000 27 35
14. S. Steiner, D. Wahl, B.L. Mangold, R. Robison, J. Raymackers, and L. Meheus Induction of the adipose differentiation-related protein in liver of etomoxir-treated rats Biochem Biophys Res Commun 218 1996 777 782
15. 2+-pump ATPase of the diabetic rat heart by lipid-lowering interventions Mol Cell Biochem 132 1994 69 80
16. H. Rupp, A. Zarain-Herzberg, and B. Maisch Drug development based on functional genomics of overloaded cardiomyocytes: CPT1 vs. PPARalpha effects of etomoxir N.S. Dhalla A. Chockalingam H.I. Berkowitz P.K. Singal Frontiers in cardiovascular health 2003 Kluwer Academic Publishers Boston 177 194